King's College London

Research portal

The Clinical Relevance of Noncriteria Antiphospholipid Antibodies

Research output: Contribution to journalArticle

Maria Laura Bertolaccini, Giovanni Sanna

Original languageEnglish
JournalSeminars in Thrombosis and Hemostasis
DOIs
Publication statusPublished - 3 May 2017

King's Authors

Abstract

While lupus anticoagulant (LA), anticardiolipin antibodies (aCL), anti-β2 glycoprotein I (anti-β2GPI) antibodies represent the best available and the most widely used tests in the investigation for antiphospholipid syndrome (APS), evidence gathered in recent years indicates that other antiphospholipid antibodies (aPL) specificities may also play a role in the syndrome. Several autoantibodies have been shown to be complexed with phospholipids other than cardiolipin, or to some domains of β2GPI, or else directed to other proteins of the coagulation cascade, and these have also been proposed to be of relevance to APS, and their diagnostic value and clinical utility are the focus of current research.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454